Article | October 11, 2017

Optimized Twenty-One Color Panel Design Using The ZE5 Cell Analyzer For Quantification Of T Cell Subsets In Stem Cell Transplant Patients

By Karl Staser, MD, PhD, John F. DiPersio, MD, PhD, William Eades, Angela Goldfain, and Nathan Trujillo, PhD

16-0720_ZE5_0035

Introduction
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the most effective treatment for patients with high risk and relapsed hematologic malignancies. When donor T cells recognize the host as foreign, they induce an immune response against the host and may cause life-threatening graft-versus-host disease (GvHD), a major complication of allo-HSCT. Monitoring T cell subsets pre- and post- transplantation in correlation with patient outcomes may identify the key cell types mediating engraftment, relapse, GvHD, and drug response. Because there are numerous T cell subset populations, many of which are rare, increasing the types that can be detected simultaneously can provide an advantage in unbiased tracking and quantification.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: